Profound Medical Corp.
NASDAQ:PROFMedical - Devices
+$0.27 today
- Market cap
- $253.09M
- Beta
- 0.52
- P/E (TTM)
- -6.3
- EPS (TTM)
- -$1.07
Volume 0.08M
Average 0.12M
PROF Inventory
Raw materials, work in progress, and finished goods held for sale.
Profound Medical Corp.NASDAQ: PROF
Inventory · Q1 FY2026 · quarter ended Mar 2026
Inventory rises 32.9% from a year ago
Inventory stood at $9.03M at the end of Q1 FY2026, up 32.9% from a year earlier and down 20.0% from the prior quarter. Over 3 fiscal years it compounded at +12.4% a year.
Context
- Inventory amounted to 12.3% of total assets at the end of Q1 FY2026, up 1.1 pp from a year earlier.
- Inventory increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether inventory keeps rising in the next quarterly balance sheet after a +32.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Inventory history
USD · from the balance sheet
- Latest · FY2025
- 11.28M USD
- Year-over-year change
- +94.5%
- 4-year CAGR
- +11.1%
| Period | Period end | Inventory | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.28M | +94.5% |
| FY2024 | 2024-12-31 | 5.8M | -17.0% |
| FY2023 | 2023-12-31 | 6.99M | -12.0% |
| FY2022 | 2022-12-31 | 7.94M | +7.3% |
| FY2021 | 2021-12-31 | 7.4M | — |
Inventory vs competitors
How PROF compares with its peers on the latest reported figures
- PROF's Mar 2026 inventory of $9.03M is the 4th highest of the 11 companies compared; the peer median is $4.25M.
- Its year-over-year change of +32.9% is the 5th highest of 9, against a peer median of +33.3%.
- Inventory amounts to 12.3% of total assets for PROF, versus a peer median of 3.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $23.1M | +50.7% | +22.4% | 34.9% | |
| Mar 2026 | $18.19M | +54.0% | -6.2% | 21.0% | |
| Mar 2026 | $14.2M | +114.8% | +15.9% | 8.1% | |
| Mar 2026 | $9.03M | +32.9% | +12.4% | 12.3% | |
| Mar 2026 | $7.63M | -7.8% | -4.2% | 3.9% | |
| Mar 2026 | $4.72M | +15.9% | -21.4% | 3.8% | |
| Mar 2026 | $3.78M | -9.2% | +27.9% | 5.3% | |
| Dec 2025 | $3.07M | +105.6% | +8.3% | 1.9% | |
AVRAnteris Technologies Global Corp. | Mar 2026 | $122K | -66.5% | +27.4% | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PROF) | $4.25M | +33.3% | +12.1% | 3.8% | |
Competitors are the stored peer set for PROF. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 67.06M | 46.52M | 26.21M | 54.91M | 81.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.41M | 6.34M | 7.29M | 7.05M | 9.86M |
| Inventory | 7.4M | 7.94M | 6.99M | 5.8M | 11.28M |
| Other Current Assets | 1.15M | 0 | 0 | 0 | 1.27M |
| Total Current Assets | 77.02M | 62.02M | 41.9M | 69.07M | 104.21M |
| Property, Plant & Equipment (Net) | 1.9M | 1.72M | 1.57M | 821.01K | 225K |
| Goodwill | 2.69M | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.43M | 680K | 490K | 261K | 138K |
| Long-term Investments | 3.62M | 0 | 0 | 0 | 410.89K |
| Tax Assets | 0 | 0 | 0 | 87K | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 87.96M |
| Total Non-current Assets | 9.64M | 2.4M | 2.06M | 1.17M | 88.73M |
| Total Assets | 86.66M | 64.42M | 43.96M | 70.23M | 192.94M |
| Account Payables | 3.18M | 2.03M | 865K | 1.32M | 2.14M |
| Short-term Debt | 249.66K | 523K | 2.1M | 1.74M | 291.73K |
| Tax Payables | 0 | 298K | 0 | 0 | 0 |
| Deferred Revenue | 476.35K | 471K | 721K | 419K | 0 |
| Other Current Liabilities | 247.66K | 621K | 1.42M | 1.03M | 5.83M |
| Total Current Liabilities | 4.15M | 4.19M | 6.37M | 6.57M | 8.32M |
| Long-term Debt | 0 | 6.65M | 5M | 2.92M | 6.16M |
| Deferred Tax Liabilities | 0 | 0 | 59K | 0 | 86.83M |
| Deferred Revenue (Non-current) | 873.82K | 764K | 728K | 49K | 531.42K |
| Other Non-current Liabilities | 0 | 0 | 73K | 71K | 108.2K |
| Total Non-current Liabilities | 2M | 8.23M | 6.36M | 3.25M | 93.63M |
| Total Liabilities | 6.15M | 12.42M | 12.73M | 9.81M | 101.95M |
| Common Stock | 219.28M | 205.83M | 222.21M | 281.55M | 443.54M |
| Retained Earnings | (160.48M) | (189.36M) | (217.35M) | (245.17M) | (394.1M) |
| Accumulated OCI | 4.74M | 16.84M | 5.57M | 2.74M | 6.88M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 80.51M | 52M | 31.22M | 60.42M | 90.99M |
| Total Debt | 1.38M | 8.23M | 7.87M | 5.12M | 6.45M |
| Net Debt | (65.69M) | (38.29M) | (18.35M) | (49.79M) | (75.34M) |
Profound Medical Corp.
NASDAQ:PROF
Intrinsic Alpha fair value
Locked
Current Price
$6.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.